Clinical Trials Logo

Clinical Trial Summary

Hip fracture has a serious impact on the quality of life and even the survival of older adults. The multidisciplinary management of hip fracture has been shown to be effective in improving patient outcome and cost-effective in international studies. As geriatricians and members of a multi-disciplinary team(MDT), we are aware of various scores in predicting the 1-year mortality risk in hospitalized older adults with multimorbidity. However, given the need for a deeper understanding of the preoperative status of elderly patients who were suffering from pain, tension, anxiety, delirium,etc., we hope to explore a simple, quick, objective, and accurate method for assessing the status of elderly patients with hip fractures to predict their survival risk.


Clinical Trial Description

This was a single-center retrospective cohort study which were approved by the Clinical Research Ethics Committee of Beijing Tongren Hospital, Capital Medical University (TREC2023-KY026). Demographic characteristics and medical parameters, such as age, gender, body mass index (BMI), comorbidities, hemoglobin , lymphocytes, C-reactive protein (CRP), fasting blood glucose, creatinine, total protein, albumin, triglycerides, total cholesterol and American Association of Anesthesiologists (ASA) were collected from the electronic medical record system. Controlling nutritional status (CONUT) was calculated from 3 variables: serum albumin concentration, total cholesterol concentration, and lymphocyte count, as previously reported. All enrolled patients were followed-up in an outpatients setting. Survival data were obtained via direct contact with patients or patients' caregiver by their physicians at the hospital , or via telephone interview of their family by dedicated coordinators and investigators. The follow-up lasted for one year and the last follow-up was ended on December 31, 2022. All analyses were performed using SPSS version 19.0 (SPSS, Chicago, IL, USA). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05814172
Study type Observational
Source Beijing Tongren Hospital
Contact YING CHEN
Phone 008613621247560
Email trchenying@mail.ccmu.edu.cn
Status Recruiting
Phase
Start date October 2023
Completion date November 2023

See also
  Status Clinical Trial Phase
Completed NCT03939624 - Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events
Completed NCT03568916 - Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)
Recruiting NCT03206593 - Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure N/A
Completed NCT01168362 - Korea Atherosclerosis Study-3 N/A
Completed NCT03596502 - Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs Warfarin)
Completed NCT02989103 - Hyperthyroid Follow-Up Study
Completed NCT03243578 - Relationship Between Dietary Protein Intake and Fatal and Non-fatal Health Outcomes N/A
Completed NCT00225368 - Effects of Insecticide Treated Bednets on Child Morbidity and Mortality N/A